These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1576712)

  • 1. Determination of malonaldehyde-modified 2'-deoxyguanosine-3'-monophosphate and DNA by 32P-postlabelling.
    Vaca CE; Vodicka P; Hemminki K
    Carcinogenesis; 1992 Apr; 13(4):593-9. PubMed ID: 1576712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a 32P-postlabelling method for the analysis of 2'-deoxyguanosine-3'-monophosphate and DNA adducts of methylglyoxal.
    Vaca CE; Fang JL; Conradi M; Hou SM
    Carcinogenesis; 1994 Sep; 15(9):1887-94. PubMed ID: 7923582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a 32P-postlabelling method for the analysis of adducts arising through the reaction of acetaldehyde with 2'-deoxyguanosine-3'-monophosphate and DNA.
    Fang JL; Vaca CE
    Carcinogenesis; 1995 Sep; 16(9):2177-85. PubMed ID: 7554072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 32P-postlabeling analysis of binding of the cyclophosphamide metabolite, acrolein, to DNA.
    Maccubbin AE; Caballes L; Scappaticci F; Struck RF; Gurtoo HL
    Cancer Commun; 1990; 2(6):207-11. PubMed ID: 2378783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 32P-postlabelling methods for cyclic DNA adducts.
    Watson WP; Crane AE; Steiner S
    IARC Sci Publ; 1993; (124):255-62. PubMed ID: 8225493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some quantitative considerations about DNA adduct enrichment procedures for 32P-postlabelling.
    Vaca CE; Löfgren M; Hemminki K
    Carcinogenesis; 1992 Dec; 13(12):2463-6. PubMed ID: 1473258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-postlabelling of DNA adducts in styrene oxide-modified DNA and in workers exposed to styrene.
    Vodicka P; Hemminki K
    IARC Sci Publ; 1993; (127):109-18. PubMed ID: 8070856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo.
    Maccubbin AE; Caballes L; Riordan JM; Huang DH; Gurtoo HL
    Cancer Res; 1991 Feb; 51(3):886-92. PubMed ID: 1988129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabelling of 2-hydroxyethylated, ethylated and methylated adducts of 2'-deoxyguanosine 3'-monophosphate.
    Koivisto P; Hemminki K
    Carcinogenesis; 1990 Aug; 11(8):1389-92. PubMed ID: 2387026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion.
    Maccubbin AE; Lee L; Struck RF; Gurtoo HL
    Chem Biol Interact; 1992 Sep; 84(1):21-35. PubMed ID: 1394614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of the 32P-postlabeling reaction using cyclic N1,N2 and C8 modified deoxyguanosine 3'-monophosphates as substrates.
    Hemminki K; Szyfter K; Kadlubar FF
    Chem Biol Interact; 1991; 77(1):51-61. PubMed ID: 1845762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of 32P-postlabelling to detect DNA adducts produced by experimental anticancer drugs: DNA-directed nitrogen mustards.
    Ferguson LR; Siegers D; Denny WA; Hewer A; Phillips D
    Anticancer Drug Des; 1994 Jun; 9(3):239-49. PubMed ID: 8031455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection by 32P-postlabelling of DNA adducts induced by free radicals and unsaturated aldehydes formed during the aerobic decomposition of fecapentaene-12.
    Povey AC; Wilson VL; Zweier JL; Kuppusamy P; O'Neill IK; Harris CC
    Carcinogenesis; 1992 Mar; 13(3):395-401. PubMed ID: 1547529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 32P-postlabeling of DNA adducts of styrene-exposed lamination workers.
    Vodicka P; Vodickova L; Hemminki K
    Carcinogenesis; 1993 Oct; 14(10):2059-61. PubMed ID: 8222054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 32P-postlabelling method for the detection of 7-alkylguanine adducts formed by the reaction of different 1,2-alkyl epoxides with DNA.
    Kumar R; Staffas J; Försti A; Hemminki K
    Carcinogenesis; 1995 Mar; 16(3):483-9. PubMed ID: 7697802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 32P-postlabelling analysis of isomeric 7-alkylguanine adducts of styrene oxide.
    Kumar R; Vodicka P; Peltonen K; Hemminki K
    Carcinogenesis; 1997 Feb; 18(2):407-14. PubMed ID: 9054636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and quantitation of hepatic DNA adducts formed in B6C3F1 mice from 1'-hydroxy-2',3'-dehydroestragole: comparison of the adducts detected with the 1'-3H-labelled carcinogen and by 32P-postlabelling.
    Fennell TR; Juhl U; Miller EC; Miller JA
    Carcinogenesis; 1986 Nov; 7(11):1881-7. PubMed ID: 3769137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
    Randerath K; Liehr JG; Gladek A; Randerath E
    IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.